Molecular Imaging: Page 278

Digirad revenues, profits decline in Q1

By AuntMinnie.com staff writers

Nuclear medicine firm Digirad reported a decline in first-quarter revenue and net income compared with the prior year's first quarter.

May 5, 2013

C-11 acetate PET/CT helps patients before prostatectomy

By Wayne Forrest

PET/CT with carbon-11 (C-11) acetate is better at detecting lymph-node metastasis among patients planning for or completing radical prostatectomy than conventional imaging, and it can help predict treatment efficacy and survival, according to a study published in the May Journal of Nuclear Medicine.

May 5, 2013

Positron joins with Biologics in comarketing deal

By AuntMinnie.com staff writers

PET firm Positron and biological facilities manufacturer Biologics Modular will collaborate in a comarketing agreement that enables Positron to offer additional clean-room capacity from Biologics for Positron's PosiRx automated radiopharmacy system.

May 2, 2013

UltraSPECT and PharmaLogic join forces

By AuntMinnie.com staff writers

Nuclear medicine firm UltraSPECT has inked a distribution agreement with nuclear radiopharmacy services provider PharmaLogic.

May 2, 2013

Dilon highlights MBI study

By AuntMinnie.com staff writers

Breast-specific gamma imaging (BSGI) provider Dilon Diagnostics is highlighting a study published in the European Journal of Nuclear Medicine and Molecular Imaging that shows molecular breast imaging (MBI) to be a useful adjunct to mammography.

May 1, 2013

PET/CT enhances detection of inflammatory bowel disease

By AuntMinnie.com staff writers

A group from the University of Münster in Germany has found that PET/CT may be able to more effectively detect and monitor inflammatory bowel disease such as Crohn's disease and ulcerative colitis, according to research published in the May issue of the Journal of Nuclear Medicine.

May 1, 2013